医学临床研究
  2025年4月6日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2019, Vol. 36 Issue (4): 675-677    DOI: 10.3969/j.issn.1671-7171.2019.04.018
  论著 本期目录 | 过刊浏览 | 高级检索 |
改良立体定向联合术中B超精准定位微创治疗高血压脑出血的临床研究
王博1, 韦明炯2, 惠一鸣3, 赵新宇4
1.西安医学院,陕西 西安 710021;
2.陕西省第二人民医院,陕西 西安 710005;
3.陕西中医药大学,陕西 咸阳 712046;
4.西安市北方医院,陕西 西安 710043
Clinical Study on Minimally Invasive Treatment of Hypertensive Intracerebral Hemorrhage by Improved Stereotaxy Plus Intraoperative B-mode Ultrasonography
WANG Bo, WEI Ming-jiong, HUI Yi-ming, et al
Xi'an Medical University ,Shaanxi 710021
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨CT改良立体定向联合术中B超精准定位微创治疗高血压脑出血的临床效果。【方法】回顾性分析2013年6月至2017年2月陕西省第二人民医院收治的82例高血压脑出血患者的临床资料,根据治疗方法的不同将其分为开颅组(常规开颅手术治疗,n=40)和微创组(CT改良立体定向+术中B超精准定位微创血肿清除治疗,n=42)。比较两组临床疗效、格拉斯哥预后量表(GOS)、昏迷评分(GCS)、神经功能缺损(NIHSS)评分、生活能力Barthel指数,记录血肿清除情况以及再出血率。【结果】两组手术时间、血肿清除率比较,差异无统计学意义(P>0.05);微创组出血量、住院时间、再出血率低于开颅组,差异有统计学意义(P<0.05)。微创组治疗有效率为83.33%(35/42)高于开颅组的70.00%(28/40),差异具有统计学意义(χ2=5.543,P=0.028<0.05)。两组术后GOS量表评级良好、中残、重残、植物生存、死亡情况比较,微创组优于开颅组(Z=-0.344,P<0.05)。两组治疗后GCS评分、Barthel指数升高,NIHSS评分降低,且微创组优于开颅组(P<0.05)。【结论】CT改良立体定向+术中B超精准定位微创治疗高血压脑出血其临床疗效、术后神经功能、生活能力改善情况较佳,且可降低再出血风险,具有出血少、住院时间短等优势。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王博
韦明炯
惠一鸣
赵新宇
关键词 颅内出血高血压性/外科学超声检查多普勒彩色    
Abstract【Objective】 To explore the clinical effect of CT modified stereotactic plus intraoperative B-ultrasonography precise localization and minimally invasive treatment of hypertensive intracerebral hemorrhage.【Methods】The clinical data of 82 patients with hypertensive intracerebral hemorrhage admitted to the Second People's Hospital of Shaanxi Province from June 2013 to February 2017 were retrospectively analyzed. According to the different treatment methods, they were divided into craniotomy group (routine craniotomy, n=40) and minimally invasive group (CT modified stereotactic + intraoperative B-ultrasonography precise positioning minimally invasive hematoma clearance treatment, n=42). The clinical efficacy, Glasgow Prognosis Scale (GOS), Coma Score (GCS), Neurological Deficiency (NIHSS), Barthel Index of Living Ability were compared between the two groups. The clearance of hematoma and the rate of rebleeding were recorded.【Results】There was no significant difference in operation time and hematoma clearance rate between the two groups (P>0.05); the amount of bleeding, hospitalization time and rebleeding rate in the minimally invasive group were lower than those in the craniotomy group (P<0.05). The effective rate of minimally invasive group was 83.33% (35/42) higher than that of craniotomy group (70.00% (28/40), and the difference was statistically significant (χ2= 5.543, P=0.028<0.05). The GOS score of the two groups was good, moderate disability, severe disability, plant survival and death. The minimally invasive group was better than the craniotomy group (Z=-0.344, P<0.05). After treatment, GCS score and Barthel index increased and NIHSS score decreased in both groups, and the minimally invasive group was better than the craniotomy group (P<0.05).【Conclusion】CT modified stereotactic plus intraoperative B-ultrasonography precise localization minimally invasive treatment of hypertensive intracerebral hemorrhage has better clinical efficacy, postoperative neurological function, life ability improvement, and can reduce the risk of re-bleeding, with less bleeding, short hospitalization time and other advantages.
Key wordsIntracranial Hemorrhage    Hypertensive
收稿日期: 2018-11-20     
PACS:  R743.34  
引用本文:   
王博, 韦明炯, 惠一鸣, 赵新宇. 改良立体定向联合术中B超精准定位微创治疗高血压脑出血的临床研究[J]. 医学临床研究, 2019, 36(4): 675-677.
WANG Bo, WEI Ming-jiong, HUI Yi-ming, et al. Clinical Study on Minimally Invasive Treatment of Hypertensive Intracerebral Hemorrhage by Improved Stereotaxy Plus Intraoperative B-mode Ultrasonography. JOURNAL OF CLINICAL RESEARCH, 2019, 36(4): 675-677.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2019.04.018     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2019/V36/I4/675
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn